Cannabis Freedom Index
← History

Medical 🇨🇩 DR Congo

DR Congo sets licensing rules for medical and scientific cannabis

DR Congo set five-year authorisations for growing and producing narcotics for medical and scientific purposes under its 2018 health law. Medical cannabis varieties had to contain no more than 0.2% THC and a high CBD content; cultivation was reserved to authorised Congolese organisations operating at industrial scale. The rules kept other purposes prohibited, and a revised order followed in 2022.[1][3]

The story

The 2018 health law promised medical cannabis under conditions the minister would set; the order of 27 February 2021 set them. Growing and producing narcotics for medical and scientific purposes needed a five-year authorisation, reserved to Congolese organisations operating at industrial scale.[1]

The order drew a hard line around the plant: medical varieties had to contain no more than 0.2% THC with high CBD content, and every non-medical purpose stayed prohibited.[1] The shape proved durable — the revised order of 24 November 2022 kept the industrial-scale authorisations, the THC ceiling and the ban on prescribing or dispensing narcotics in kind.[2]

What the orders built was a licensed production framework with no patients at the end of it. Authorisations run to exclusively industrial organisations, imports and exports of semi-finished and finished products need authorisation while raw cannabis exports are prohibited, and no operating patient supply was verified.[2]

Listed for context. No score change is recorded for DR Congo here.

References

  1. Ministerial Order 1250/CAB/MIN/S/0002/DC/OWE/2021 of 27 February 2021archived
  2. DR Congo — Ministerial order 1250/CAB/MIN/SPHP/038/DCA/CPh/2022 of 24 November 2022archived
  3. Wikipedia — Cannabis in the Democratic Republic of the Congoarchived

Checked. The date and the event were compared with a source that was read.

    ↑↓ to move, ↵ to open.